Battle of the blood clots: Tailored glycopolymers as anticoagulant heparin mimetics
Friday, October 11, 2013 - 07:20
in Health & Medicine
(Phys.org) —One of the risks of any large operation is the occurrence of blood clots. To prevent this, patients are routinely given the anticoagulant heparin or related drugs. American scientists have now introduced a new approach to the production of synthetic heparin mimetics with better activity profiles.